In previous studies, FAR or AFR (albumin to fibrinogen ratio) was proved to be related to a systemic inflammatory response in various malignant tumors, including but not limited to gastric, esophageal, lung and cervical cancers [17–20]. This evidence concerns the gene ALB and cancer.